Driven by science, powered by expertise

1928 Diagnostics’ mission is to combat antimicrobial resistance and limit the spread of infectious disease by providing healthcare facilities and laboratories with innovative bioinformatics solutions. By providing user-friendly, accessible and scalable solutions, we deliver fast and accurate results that supports the global healthcare community in tackling the most pressing medical challenges of our time.

Our mission

Antimicrobial resistance (AMR) is one of the greatest global health challenges of our time. In 2019 alone, bacterial AMR was directly responsible for 1.27 million deaths worldwide and contributed to an alarming 4.95 million deaths.

Without decisive action, the future looks even more dire. By 2050, projections indicate that deaths caused by antibiotic-resistant infections could rise to 1.91 million annually, with total associated deaths potentially reaching a staggering 8.22 million each year.

1928 Diagnostics was founded to be part of the solution to this growing crisis. By providing advanced tools and support for detecting and analyzing AMR, we empower healthcare professionals, researchers and industry to take effective, data-driven actions. Together, we aim to slow the spread of resistance and ensure a future where antibiotics remain a vital resource for global health.